Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. - Wikidata - wikimedia - TriplyDB

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

http://www.wikidata.org/entity/Q39896037

about

Management of HBV and HBV/HDV-Associated Liver Cirrhosis Personalized management of cirrhosis by non-invasive tests of liver fibrosis.Molecular prognostic prediction in liver cirrhosis Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy Prevention of hepatocellular carcinoma in patients with chronic hepatitis B Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Screening for hepatocellular carcinoma: patient selection and perspectives Risk prediction models for hepatocellular carcinoma in different populations.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.Domain Analysis of Integrated Data to Reduce Cost Associated with Liver Disease.Hepatitis B virus infection and alcohol consumption Risk calculators for hepatocellular carcinoma in patients affected with chronic hepatitis B in Asia.Immune Tolerant Chronic Hepatitis B: The Unrecognized Risks Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B.The G1613A mutation in the HBV genome affects HBeAg expression and viral replication through altered core promoter activity Predictability of liver-related seromarkers for the risk of hepatocellular carcinoma in chronic hepatitis B patients.Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma.Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database.Personalized treatment of hepatitis B.Genotypes, mutations, and viral load of hepatitis B virus and the risk of hepatocellular carcinoma: HBV properties and hepatocarcinogenesis.Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Clinicopathological features and prognostic factors of young patients with surgically treated liver cancer A microRNA-based prediction model for lymph node metastasis in hepatocellular carcinoma.Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases Virus and Host Testing to Manage Chronic Hepatitis B.Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection.New perspectives of biomarkers for the management of chronic hepatitis B.Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China.Is there any value to hepatitis B virus genotype analysis?Natural history of chronic hepatitis B: what exactly has REVEAL revealed?

P2860

Q26740323-211535ED-E51F-4573-8585-F5C12987C679 Q26777483-E89A48AE-3B2A-4890-80B8-91E781F523A6 Q26784251-EF06F32E-DB77-45BB-8600-69DEEBEAEB06 Q27022899-40F3709A-F4BF-47A4-96E1-68719DF2290B Q27023997-C0130728-3517-4A88-BDBC-FB1CF868DB0C Q28066959-19F50CBA-4B03-4627-A8F4-6B2C47391394 Q28075923-A3550648-AB32-4452-A7D6-120652C34A37 Q30244651-F1A9D595-9075-4BA8-A7F8-2D610D4F900B Q30355713-F7A1EC40-BBF6-42FF-9326-77497DA86D7D Q30383460-D72A0ADE-8660-4539-AF51-E518EE491673 Q30391932-295B55D1-F0CD-4EE8-8424-83D5FF845E77 Q30392056-A380E4DE-8692-4A26-87EF-7A797A9C7CBF Q30986369-BF82EA08-6543-462A-BAE1-06FBDCB6DF98 Q33599503-836303F5-602B-419E-90DB-CBDDD7890706 Q33661164-33F1DD22-8B6D-41CC-9087-C3F4DF460D4F Q33753902-8A60F600-683F-47D6-A485-CA23EBAF81FB Q33872964-02C4E990-864C-46F0-803D-1A3D2ACB82F1 Q33981411-EF035E0D-E00E-4C52-848B-6B2BFF0348E1 Q34684406-FBF58990-FC1D-4537-8410-9355C3F0154C Q34892826-3D3EBFA1-F5A4-4798-AB8C-8351881A41AE Q35051831-2B9AC782-F67E-4E61-8839-AA33825DB821 Q35115406-5781C19D-1B0E-440D-BEFC-C31EDFEE419F Q35176097-7F08D894-0947-40BB-893E-4485D7A53901 Q35231805-CC60BB29-0B8A-4C2A-84B7-73A40644B853 Q35507447-6F2CC34D-625A-4D4C-B919-3FDA82C0B696 Q35668724-E38A5589-7EAF-40C7-982C-2828D5C54354 Q35881575-8BE63BC7-1F62-4ADD-84C6-509D654F5DF8 Q36009055-270CD64C-8E63-4618-BA06-3B2005AF0C17 Q36772208-578F10C6-DF73-4C66-B90C-E4C00FDE3FE1 Q36933865-D741E5BA-8B9C-4B8E-8FA8-8260B4A100DF Q36954705-4CC3DB99-1440-4D02-881B-09BFBE058E71 Q36958940-5FD81EF4-2CCB-4B91-A8BC-A5DAE04AA227 Q37117293-9146E3A2-7100-407E-90C1-8E54B9B55808 Q37241565-EEE936A8-9965-42AE-8EB0-060BD9A8148A Q37257069-E36FBB05-C2A0-48DF-A6A7-0126E5940ABF Q37408920-85606B84-5DE5-4DAE-A9D8-B916EA99CBAF Q37606546-A6D3695B-2A54-4F82-A928-265AC40E5D8F Q37702167-D1AAECC6-A5C9-4D7B-9E51-164E2123696F Q37959290-D0C323FD-A223-438C-A329-2BF42A767709 Q38003214-5422F9C0-0D05-495A-94BA-4411C425A1BE

P2860

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

http://www.wikidata.org/entity/Q39896037

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Clinical scoring system to pre ...... chronic hepatitis B carriers.

@en

Clinical scoring system to pre ...... chronic hepatitis B carriers.

@nl

type

label

Clinical scoring system to pre ...... chronic hepatitis B carriers.

@en

Clinical scoring system to pre ...... chronic hepatitis B carriers.

@nl

prefLabel

Clinical scoring system to pre ...... chronic hepatitis B carriers.

@en

Clinical scoring system to pre ...... chronic hepatitis B carriers.

@nl

P1433

Q39896037-6B4B780E-0DFC-4E8B-B10A-856FCDB4A6DE

P1476

Q39896037-749D7E90-84D1-4E29-BEA6-F86B262D1DA8

P2093

Q39896037-3950C081-3B0F-4A72-9C3E-B89ECE801D4B

Q39896037-4547AC40-0376-4574-AA51-CD1D0E7B50D1

Q39896037-554B18DE-5465-433B-83BB-D8D9B06787D1

Q39896037-8909D332-BBAD-4BAB-8A8F-06869342D758

Q39896037-A76622E9-BB45-474B-9923-315745989213

Q39896037-AEEE9EA5-382F-4675-A202-EF50706C53AF

Q39896037-CD50851D-954A-4FD8-9EF3-4E5F4C63CCFF

Q39896037-F54921C6-4D19-4345-A3D7-F9301CA04C0E

P304

Q39896037-A64828D9-C329-4475-864E-F97D0AD4BAE9

P31

Q39896037-CC92E4F7-2094-49BA-BCD5-8534495B40D0

P356

Q39896037-06AB5ABB-137A-4758-B046-F771A964083F

P407

Q39896037-F846CC9F-BBE9-47A3-A551-86CA99C93661

P433

Q39896037-85A1C4BA-2F64-4170-BEE3-B344F3644F1C

P478

Q39896037-33850CE6-F238-4DE8-8531-E2BAAEDAF410

P50

Q39896037-07CDC4C8-432C-4D9F-9CAE-42009AAE247D

Q39896037-655B3153-EB70-4001-B0CD-5DE7D1B507D0

Q39896037-97CEA573-7BA2-47F0-965D-182C5F92705B

Q39896037-9ABCE462-D155-42E0-9649-42DDF01FB990

P577

Q39896037-2C94D2FD-B19F-4526-AF6C-C893CCAFD2DD

P698

Q39896037-820CC297-A180-4DF6-9193-523B29E55EC9

P356

JCO.2009.26.2675

P1433

Journal of Clinical Oncology

P1476

Clinical scoring system to pre ...... n chronic hepatitis B carriers

@en

P2093

Anthony Tak-Cheung Chan

http://www.w3.org/2001/XMLSchema#string

Frankie Mo

http://www.w3.org/2001/XMLSchema#string

Grace Lai-Hung Wong

http://www.w3.org/2001/XMLSchema#string

Henry Lik-Yuen Chan

http://www.w3.org/2001/XMLSchema#string

Stephen Lam Chan

http://www.w3.org/2001/XMLSchema#string

Tung-Ching Chan

http://www.w3.org/2001/XMLSchema#string

Vincent Wai-Sun Wong

http://www.w3.org/2001/XMLSchema#string

Yanni Yan-Ni Lui

http://www.w3.org/2001/XMLSchema#string

P304

1660-1665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2009.26.2675

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Joseph J Y Sung

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20194845

http://www.w3.org/2001/XMLSchema#string